‘Idiopathic’ partial androgen insensitivity syndrome in 28 newborn and infant males: impact of prenatal exposure to environmental endocrine disruptor chemicals?

Objective46,XY disorders of sex differentiation (46,XY DSD) can be due to a testis determination defect, an androgen biosynthesis defect, or androgen resistance (complete or partial androgen insensitivity syndrome (PAIS), or 5α reductase deficiency). We aimed to evaluate the impact of a prenatal con...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of endocrinology Vol. 165; no. 4; pp. 579 - 587
Main Authors Gaspari, Laura, Paris, Françoise, Philibert, Pascal, Audran, Françoise, Orsini, Mattea, Servant, Nadège, Maïmoun, Laurent, Kalfa, Nicolas, Sultan, Charles
Format Journal Article
LanguageEnglish
Published Bristol BioScientifica 01.10.2011
European Society of Endocrinology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective46,XY disorders of sex differentiation (46,XY DSD) can be due to a testis determination defect, an androgen biosynthesis defect, or androgen resistance (complete or partial androgen insensitivity syndrome (PAIS), or 5α reductase deficiency). We aimed to evaluate the impact of a prenatal contamination by environmental xenoestrogens in ‘idiopathic’ PAIS-like phenotype.SubjectsWe investigated 28 newborn/infant males with 46,XY DSD, normal androgen production, and no androgen receptor or steroid-5αR type II enzyme (SRD5A2) gene mutations.MethodsTo exclude other genetic defects, we sequenced the steroidogenic factor 1 (SF1) and mastermind-like domain-containing 1 (MAMLD1) genes, which were recently found to be associated with the PAIS-like phenotype. Parents were interviewed about their environmental/occupational exposure to endocrine disrupting chemicals (EDCs) before/during the patients' fetal life. Total estrogenic bioactivity of patient serum was analyzed by ultrasensitive bioassay.ResultsAll the patients had normal SF1 sequence and one patient showed a double polymorphism of MAMLD1. Eleven (39.3%) of the 28 patients had reported parental fetal exposure to EDCs. The mean estrogenic bioactivity in these 11 patients with fetal EDC exposure (6.65±8.07 pg/ml) versus 17 cases without contamination (1.27±0.34 pg/ml) and controls (1.06±0.44 pg/ml; P<0.05) was elevated.ConclusionsOur results indicate that the ‘idiopathic’ PAIS-like phenotype may in some cases be related to EDC contamination during fetal life.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0804-4643
1479-683X
1479-683X
DOI:10.1530/EJE-11-0580